Načítá se...
Procaine Induces Epigenetic Changes in HCT116 Colon Cancer Cells
Colon cancer is the third most commonly diagnosed cancer in the world, and it is the major cause of morbidity and mortality throughout the world. The present study aimed at treating colon cancer cell line (HCT116) with different chemotherapeutic drug/drug combinations (procaine, vorinostat “SAHA,” s...
Uloženo v:
| Vydáno v: | Genet Res Int |
|---|---|
| Hlavní autoři: | , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Hindawi Publishing Corporation
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5098101/ https://ncbi.nlm.nih.gov/pubmed/27843649 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/8348450 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|